H Kosiorek
No ORCID on file
· 1 paper in corpus
nonrandomized-trial
2017
Myelofibrosis is a myeloproliferative neoplasm that is characterized by splenomegaly, profound symptom burden, and cytopenias. JAK inhibitor therapy offers improvements in splenomegaly, symptom burden, and potentially survival; however, cyt…